Biochip platforms as functional genomics tools for drug discovery.
暂无分享,去创建一个
[1] Gary Hardiman,et al. Microarray platforms--comparisons and contrasts. , 2004, Pharmacogenomics.
[2] Jonathan Knight,et al. When the chips are down , 2001, Nature.
[3] R. Lempicki,et al. Evaluation of gene expression measurements from commercial microarray platforms. , 2003, Nucleic acids research.
[4] James L. Winkler,et al. Accessing Genetic Information with High-Density DNA Arrays , 1996, Science.
[5] Ravi Kothapalli,et al. Microarray results: how accurate are they? , 2002, BMC Bioinformatics.
[6] Jiang Li,et al. Differential gene expression patterns revealed by oligonucleotide versus long cDNA arrays. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[7] Sangsoo Kim,et al. Combining multiple microarray studies and modeling interstudy variation , 2003, ISMB.
[8] D. Nickerson,et al. Variation is the spice of life , 2001, Nature Genetics.
[9] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[10] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[11] R. Shippy,et al. An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. , 2002, Nucleic acids research.
[12] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Kennedy. Managing the drug discovery/development interface , 1997 .
[15] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[16] T. Barrette,et al. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. , 2002, Cancer research.
[17] M. Reinders,et al. Genetic network modeling. , 2002, Pharmacogenomics.
[18] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[19] Z. Szallasi,et al. Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. , 2004, Nucleic acids research.
[20] Karl Kornacker,et al. Chipping away at the chip bias: RNA degradation in microarray analysis , 2003, Nature Genetics.
[21] Jaak Vilo,et al. Regulatory sequence analysis: application to the interpretation of gene expression , 2001, European Neuropsychopharmacology.
[22] Kristina Hanspers,et al. Spotted long oligonucleotide arrays for human gene expression analysis. , 2003, Genome research.
[23] Lucila Ohno-Machado,et al. Analysis of matched mRNA measurements from two different microarray technologies , 2002, Bioinform..
[24] W. Wong,et al. Functional annotation and network reconstruction through cross-platform integration of microarray data , 2005, Nature Biotechnology.
[25] P. Brown,et al. Drug target validation and identification of secondary drug target effects using DNA microarrays , 1998, Nature Medicine.
[26] G. Churchill,et al. A comparison of cDNA, oligonucleotide, and Affymetrix GeneChip gene expression microarray platforms. , 2004, Journal of biomolecular techniques : JBT.
[27] Julie A. Johnson. Drug Target Pharmacogenomics , 2001 .
[28] Carole L Yauk,et al. Comprehensive comparison of six microarray technologies. , 2004, Nucleic acids research.
[29] R G Ulrich,et al. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.
[30] D. Davison,et al. d2_cluster: a validated method for clustering EST and full-length cDNAsequences. , 1999, Genome research.
[31] Yudong D. He,et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.
[32] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[33] Richard S Paules,et al. An overview of toxicogenomics. , 2002, Current issues in molecular biology.
[34] David Haussler,et al. Gene structure-based splice variant deconvolution using a microarry platform , 2003, ISMB.